$165.41+41.26% · 3M
Moving avg
1W+0.54%
1M-3.88%
3M+42.13%
6M+77.86%
YTD-12.33%
1Y-5.68%
3Y-36.19%
5Y-31.20%
52-week range
$66.5772% of range$203.91
Company health
Value4/6
Growth4/6
Profitability3/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (354%)
- Revenue compounding 17% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$12.66B
Enterprise value
$14.57B
P/E ratio (TTM)
36.56x
P/S ratio (TTM)
1.46x
EV/EBITDA
11.71x
Per share & returns
EPS (TTM)
$4.28
Dividend yield
0.00%
Beta (1Y)
1.22
30-day change
-3.88%
Trading
Volume (24h)
112.49K
Previous close
$167.17
Shares outstanding
76.57M
About ICON Public Limited Company
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
ICLR
ICON Public Limited Company is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ under the ticker ICLR.
Frequently asked questions
What is ICON Public Limited Company's market cap?
ICON Public Limited Company (ICLR) has a market capitalization of $12.66B.
What is ICON Public Limited Company's P/E ratio?
ICON Public Limited Company trades at a price-to-earnings (P/E) ratio of 36.56.
What exchange does ICLR trade on?
ICLR trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,221.41+0.09%
$1.15T cap
Johnson & JohnsonJNJ
$261.39+0.20%
$629.92B cap
AbbVie Inc.ABBV
$250.64+0.76%
$442.83B cap
UnitedHealth Group IncorporatedUNH
$403.17-0.60%
$366.14B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap